| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 8.93% | Morgan Stanley | $61 → $60 | Maintains | Underweight |
| 10/26/2023 | 5.3% | Piper Sandler | $64 → $58 | Maintains | Neutral |
| 10/26/2023 | 10.75% | Morgan Stanley | $63 → $61 | Maintains | Underweight |
| 10/05/2023 | 23.46% | Oppenheimer | $71 → $68 | Maintains | Outperform |
| 10/03/2023 | 16.19% | Piper Sandler | $65 → $64 | Maintains | Neutral |
| 10/03/2023 | 14.38% | Morgan Stanley | $65 → $63 | Maintains | Underweight |
| 07/27/2023 | 23.46% | Keefe, Bruyette & Woods | $66 → $68 | Maintains | Market Perform |
| 07/27/2023 | 18.01% | Morgan Stanley | $62 → $65 | Maintains | Underweight |
| 07/05/2023 | 28.9% | Oppenheimer | $68 → $71 | Maintains | Outperform |
| 07/05/2023 | 12.56% | Morgan Stanley | $60 → $62 | Maintains | Underweight |
| 06/01/2023 | 8.93% | Morgan Stanley | $58 → $60 | Maintains | Underweight |
| 04/04/2023 | 23.46% | Oppenheimer | → $68 | Reiterates | → Outperform |
| 04/03/2023 | 5.3% | Morgan Stanley | $54 → $58 | Maintains | Underweight |
| 03/29/2023 | 8.93% | Piper Sandler | → $60 | Initiates Coverage On | → Neutral |
| 02/01/2023 | -1.96% | Morgan Stanley | $53 → $54 | Maintains | Underweight |
| 01/26/2023 | 23.46% | Oppenheimer | $65 → $68 | Maintains | Outperform |
| 12/01/2022 | -3.78% | Morgan Stanley | $51 → $53 | Maintains | Underweight |
| 11/23/2022 | 14.38% | Goldman Sachs | $56 → $63 | Maintains | Neutral |
| 11/16/2022 | 21.64% | Oppenheimer | $59 → $67 | Maintains | Outperform |
| 10/04/2022 | -7.41% | Morgan Stanley | $52 → $51 | Maintains | Underweight |
| 07/21/2022 | -5.59% | Morgan Stanley | $55 → $52 | Maintains | Underweight |
| 07/15/2022 | -0.15% | Keefe, Bruyette & Woods | $62 → $55 | Maintains | Market Perform |
| 07/12/2022 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 07/06/2022 | -0.15% | Morgan Stanley | $58 → $55 | Maintains | Equal-Weight |
| 06/02/2022 | 5.3% | Morgan Stanley | $62 → $58 | Maintains | Equal-Weight |
| 04/21/2022 | 12.56% | Morgan Stanley | $68 → $62 | Maintains | Equal-Weight |
| 03/28/2022 | 18.01% | Goldman Sachs | $67 → $65 | Downgrades | Buy → Neutral |
| 03/28/2022 | 23.46% | Morgan Stanley | $75 → $68 | Maintains | Equal-Weight |
| 01/27/2022 | 27.09% | Oppenheimer | $75 → $70 | Maintains | Outperform |
| 11/03/2021 | 21.64% | Truist Securities | → $67 | Initiates Coverage On | → Hold |
| 11/02/2021 | 21.64% | Truist Securities | → $67 | Initiates Coverage On | → Hold |
| 07/22/2021 | 36.17% | Oppenheimer | $72 → $75 | Maintains | Outperform |
| 04/22/2021 | 34.35% | Morgan Stanley | $75 → $74 | Maintains | Equal-Weight |
| 04/01/2021 | 36.17% | Morgan Stanley | $74 → $75 | Maintains | Equal-Weight |
| 01/28/2021 | 34.35% | Morgan Stanley | $72 → $74 | Maintains | Equal-Weight |
| 01/06/2021 | 28% | Goldman Sachs | → $70.5 | Initiates Coverage On | → Buy |
| 11/30/2020 | 30.72% | Morgan Stanley | → $72 | Downgrades | Overweight → Equal-Weight |
| 10/06/2020 | 14.38% | Morgan Stanley | → $63 | Initiates Coverage On | → Overweight |
| 04/24/2020 | 5.3% | Oppenheimer | $60 → $58 | Maintains | Outperform |
| 04/15/2019 | — | Keefe, Bruyette & Woods | Downgrades | Outperform → Market Perform |
What is the target price for SEI Inv (SEIC)?
The latest price target for SEI Inv (NASDAQ: SEIC) was reported by Morgan Stanley on November 2, 2023. The analyst firm set a price target for $60.00 expecting SEIC to rise to within 12 months (a possible 8.93% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SEI Inv (SEIC)?
The latest analyst rating for SEI Inv (NASDAQ: SEIC) was provided by Morgan Stanley, and SEI Inv maintained their underweight rating.
When is the next analyst rating going to be posted or updated for SEI Inv (SEIC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SEI Inv, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SEI Inv was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating SEI Inv (SEIC) correct?
While ratings are subjective and will change, the latest SEI Inv (SEIC) rating was a maintained with a price target of $61.00 to $60.00. The current price SEI Inv (SEIC) is trading at is $55.08, which is out of the analyst's predicted range.